This inventor holds 3 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Institut Gustave Roussy, Assistance Publique - Hopitaux De Paris (Aphp), Institut Pasteur. Active years: 2018-2026.
Location History:
- Villejuif, FR (2018)
- Bry-sur-Marne, FR (2023)
Company Filing History:
3 out of 101 
1 out of 77 
1 out of 897 
Years Active: 2018-2026
Title: Awatef Allouch: Innovator in Cancer and HIV Research
Introduction
Awatef Allouch is a prominent inventor based in Villejuif, France. She has made significant contributions to the fields of cancer treatment and HIV research. With a total of 3 patents, her work focuses on innovative methods that enhance therapeutic efficacy.
Latest Patents
One of her latest patents is titled "NOX2 as a biomarker of radiotherapy efficiency in cancer patients." This invention explores the role of tumor-associated macrophages in response to radiotherapy. The research reveals that ionizing radiation activates macrophages through the expression of interferon-regulatory factor 5 (IRF5). This activation is crucial for macrophage reprogramming after treatments with various agents, including γ-interferon and cis-platin. The study identifies a novel signaling pathway that may improve the effectiveness of radiotherapy by reprogramming tumor-infiltrating macrophages.
Another significant patent involves "Methods and pharmaceutical compositions for treating human immunodeficiency virus type 1 (HIV-1) infections." This invention provides a method for treating HIV-1 infection by administering an inhibitor of SGT1 activity or expression. This approach offers a promising avenue for therapeutic intervention in HIV-1 infections.
Career Highlights
Awatef Allouch has worked with esteemed institutions such as Institut Gustave Roussy and Institut National de la Santé et de la Recherche Médicale. Her research has been pivotal in advancing our understanding of cancer biology and HIV treatment.
Collaborations
Throughout her career, she has collaborated with notable colleagues, including Jean-Luc Perfettini and Eric Deutsch. These partnerships have contributed to her innovative research and the development of her patents.
Conclusion
Awatef Allouch is a trailblazer in the fields of cancer and HIV research. Her innovative patents and collaborations highlight her commitment to advancing medical science. Her work continues to pave the way for new therapeutic strategies that could significantly impact patient care.